サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/09 | 872 | 888 | 862 | 874 | +10 | +1.2% | 602,700 |
| 2022/11/08 | 861 | 872 | 845 | 864 | +7 | +0.8% | 608,100 |
| 2022/11/07 | 824 | 859 | 818 | 857 | +34 | +4.1% | 564,000 |
| 2022/11/04 | 825 | 826 | 802 | 823 | -1 | -0.1% | 631,600 |
| 2022/11/02 | 821 | 838 | 815 | 824 | -2 | -0.2% | 763,800 |
| 2022/11/01 | 865 | 875 | 818 | 826 | -47 | -5.4% | 2,298,300 |
| 2022/10/31 | 870 | 886 | 867 | 873 | -109 | -11.1% | 2,746,100 |
| 2022/10/28 | 986 | 994 | 980 | 982 | -9 | -0.9% | 329,200 |
| 2022/10/27 | 968 | 995 | 964 | 991 | +19 | +2% | 717,800 |
| 2022/10/26 | 997 | 1,014 | 972 | 972 | -2 | -0.2% | 1,148,200 |
| 2022/10/25 | 968 | 997 | 960 | 974 | ±0 | ±0% | 1,605,700 |
| 2022/10/24 | 995 | 1,009 | 974 | 974 | -24 | -2.4% | 2,111,500 |
| 2022/10/21 | 980 | 1,042 | 976 | 998 | -220 | -18.1% | 5,563,100 |
| 2022/10/20 | 1,244 | 1,245 | 1,210 | 1,218 | -44 | -3.5% | 469,700 |
| 2022/10/19 | 1,278 | 1,289 | 1,251 | 1,262 | +3 | +0.2% | 368,300 |
| 2022/10/18 | 1,263 | 1,286 | 1,255 | 1,259 | +9 | +0.7% | 446,300 |
| 2022/10/17 | 1,248 | 1,296 | 1,242 | 1,250 | +10 | +0.8% | 553,200 |
| 2022/10/14 | 1,210 | 1,247 | 1,196 | 1,240 | +64 | +5.4% | 544,500 |
| 2022/10/13 | 1,217 | 1,219 | 1,173 | 1,176 | -38 | -3.1% | 538,700 |
| 2022/10/12 | 1,215 | 1,241 | 1,190 | 1,214 | -3 | -0.2% | 461,200 |
| 2022/10/11 | 1,235 | 1,237 | 1,202 | 1,217 | -27 | -2.2% | 399,200 |
| 2022/10/07 | 1,303 | 1,343 | 1,240 | 1,244 | -65 | -5% | 916,300 |
| 2022/10/06 | 1,213 | 1,330 | 1,212 | 1,309 | +95 | +7.8% | 1,791,500 |
| 2022/10/05 | 1,191 | 1,218 | 1,168 | 1,214 | +25 | +2.1% | 516,600 |
| 2022/10/04 | 1,230 | 1,232 | 1,180 | 1,189 | -41 | -3.3% | 670,000 |
| 2022/10/03 | 1,230 | 1,251 | 1,206 | 1,230 | -1 | -0.1% | 462,200 |
| 2022/09/30 | 1,236 | 1,264 | 1,227 | 1,231 | -17 | -1.4% | 475,600 |
| 2022/09/29 | 1,166 | 1,270 | 1,166 | 1,248 | +98 | +8.5% | 1,547,300 |
| 2022/09/28 | 1,179 | 1,215 | 1,139 | 1,150 | -23 | -2% | 540,800 |
| 2022/09/27 | 1,150 | 1,220 | 1,135 | 1,173 | +29 | +2.5% | 763,200 |
| 2022/09/26 | 1,126 | 1,156 | 1,114 | 1,144 | -18 | -1.5% | 397,200 |
| 2022/09/22 | 1,098 | 1,176 | 1,087 | 1,162 | +43 | +3.8% | 623,900 |
| 2022/09/21 | 1,141 | 1,141 | 1,109 | 1,119 | -34 | -2.9% | 433,100 |
| 2022/09/20 | 1,170 | 1,172 | 1,118 | 1,153 | -19 | -1.6% | 633,000 |
| 2022/09/16 | 1,088 | 1,173 | 1,080 | 1,172 | +109 | +10.3% | 1,042,300 |
| 2022/09/15 | 1,124 | 1,124 | 1,058 | 1,063 | -55 | -4.9% | 973,100 |
| 2022/09/14 | 1,101 | 1,125 | 1,098 | 1,118 | -13 | -1.1% | 303,900 |
| 2022/09/13 | 1,154 | 1,160 | 1,130 | 1,131 | -23 | -2% | 280,800 |
| 2022/09/12 | 1,157 | 1,157 | 1,132 | 1,154 | +8 | +0.7% | 279,400 |
| 2022/09/09 | 1,114 | 1,155 | 1,100 | 1,146 | +45 | +4.1% | 545,800 |
| 2022/09/08 | 1,103 | 1,109 | 1,092 | 1,101 | +3 | +0.3% | 256,300 |
| 2022/09/07 | 1,119 | 1,123 | 1,086 | 1,098 | -22 | -2% | 452,600 |
| 2022/09/06 | 1,117 | 1,133 | 1,115 | 1,120 | +3 | +0.3% | 353,200 |
| 2022/09/05 | 1,130 | 1,131 | 1,110 | 1,117 | -29 | -2.5% | 498,900 |
| 2022/09/02 | 1,133 | 1,152 | 1,114 | 1,146 | +3 | +0.3% | 393,400 |
| 2022/09/01 | 1,169 | 1,182 | 1,142 | 1,143 | -40 | -3.4% | 325,300 |
| 2022/08/31 | 1,154 | 1,195 | 1,147 | 1,183 | +22 | +1.9% | 365,800 |
| 2022/08/30 | 1,140 | 1,165 | 1,138 | 1,161 | +9 | +0.8% | 284,100 |
| 2022/08/29 | 1,190 | 1,213 | 1,145 | 1,152 | -73 | -6% | 766,200 |
| 2022/08/26 | 1,178 | 1,273 | 1,174 | 1,225 | +58 | +5% | 1,585,200 |
651～
700
件表示中 / 2503件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 217,100円 | - | - | 0.00% | - | 100.56倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 379,000円 | -6.4% | -71.8% | 5.01% | 42.33倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 311,500円 | +21.7% | +999.9% | 0.00% | 13.05倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 293,400円 | +7.9% | -3.3% | 2.73% | 8.16倍 | 0.84倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 204,200円 | +3.1% | -6.5% | 2.35% | 9.47倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
